References
- Bond K, Horvath T, Harvey K, et al. The Cochran Library and mother-to-child transmission of HIV: an umbrella review. Evid.-Based Child Health 2007; 2:4–24.
- National HIV and syphilis antenatal sero-prevalence survey in South Africa 2006. Department of Health, Pretoria.
- DHIS: District Health Information System Database. National Department of Health. (Data extracted June 2006).
- 3rd South African AIDS Conference: Building consensus on prevention, treatment and care. 5–8 June 2007; Durban.
- National Strategic Plan for 2007 to 2011 compiled by the South African National AIDS Council (SANAC), Pretoria.
- Lattemant M, Jourdain G, Le Coeur S. Singledose perinatal nevirapine plus standard zidovidine to prevent mother-to-child transmission of HIV-1 in Thailand. N Eng J Med 2004; 351: 217–228
- Antiretroviral Treatment Protocol—Adults, Provincial Administration Western Cape, November 2003.
- Summary PMTCT Protocol Revised, Western Cape Province, September 2003.
- Jourdain G, Ngo-Giang-Huong N, Le Coeur S, et al. Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy. N Engl J Med 2004; 351: 229–40
- Healthcare Professional Newsletter, December 2006, Issue 15 produced by Aid of AIDS.
- Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999; 354:794–802.
- Moodley D, Moodley J, Coovadia H, et al. A multicenter randomised controlled trial of nevirapine versus combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type. J Infect Disease 2003; 187: 725–735.
- Cressey TR, Jourdain G, Lallemant MJ, et al. Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1. Acquir Immune Defic Syndr 2005; 38:283–8.
- Prospective Mother/Infant Study: 101 Infants in PMTCT at Mulago Hospital, Uganda Eure C et al. 13th CROI, Denver CO 2006 Abs. 125.
- European Collaborative Group. Risk factors for mother-to-child transmission of HIV-1. Lancet 1992; 339: 1007–1012.
- Davies G, Wilson RD, Désilets V, et al. Amnio- centesis and women with hepatitis B, hepatitis C, or human immunodeficiency virus. J Obstet Gynaecol Can 2003; 25(2): 145–148.
- Somigliana E, Bucceri AM, Tibaldi C, et al. Early invasive diagnostic techniques in pregnant women who are infected with the HIV: a multicentre case series. Am J Obstet Gynecol 2005; 193(2): 437–442.
- Holmes WR, Hofmeyr GJ. Management of breech presentation in areas with high prevalence of HIV infection. Int J Gynecol Obstet 2004; 87: 272–276.
- Biggar RJ, Miotti PG, Taha TE, Mtimavalye L, Broadhead R, Justesen A, et al. Perinatal intervention trial in Africa: effect of birth canal cleansing intervention to prevent HIV transmission. Lancet 1996; 347: 1647–1650.
- European Mode of Delivery Collaboration. Elective caesarean-section versus vaginal delivery in prevention of vertical transmission: a randomised clinical trial. Lancet 1999; 353: 1035–39.
- Read JS, Newell ML. Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1. Cochrane Database of Systematic Reviews 2005, Issue 4. Art No.: CD005479. DOI: 10.1002/14651858. CD005479.